- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Debate on HPV Screening in Cervical Cancer
Following FDA approval of a DNA test to detect the HPV virus last year, the medical community is split over which test is more appropriate as a primary screen for cervical cancer in women.
Two medical groups say doctors could replace the Pap smear with a different test to screen many women for cervical cancer.
But that recommendation, included in an "interim guidance" released Thursday, is highly controversial; other experts call it premature.
For years, physicians have recommended that women routinely get Pap smears to catch any signs of cervical cancer early. That strategy, which requires taking a scraping of cervical cells to check for signs of abnormalities that can presage cancer, has significantly reduced the number of U.S. women who get the disease and die from it.
But the human papilloma virus is now thought to cause most cases of cervical cancer; last spring the Food and Drug Administration approved a test for the HPV virus as a primary screening test for the malignancy. That move by the FDA prompted an intense debate about whether an HPV test should merely supplement or perhaps replace the Pap test.
Link to the complete article on NPR: http://n.pr/1xVzM5y
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
